Greater Copenhagen Health Science Partners

Så er der mulighed for at komme med på holdet hos GCHSP! Vi er i gang med en hel masse spændende tiltag i GCHSP - og vi mangler en kollega, der bl.a. skal være med til at understøtte afholdelsen af matchmakingevents, forskningskonference samt udvikle vores website. Så vil du være med til at skabe rammerne for fremragende translationel forskning og uddannelse på sundhedsområdet? Så er du måske vores kommende kollega og drivkraft i sekretariatet for Greater Copenhagen Health Science Partners. Vi bor på Rigshospitalet og er i løbende, tæt kontakt med ledelse og medarbejdere hos alle fire partnerorganisationer: DTU - Technical University of Denmark Københavns Universitet - University of Copenhagen Region Sjælland og Region Hovedstaden. Ruth Frikke-Schmidt Trine Middelbo Læs meget mere her: https://lnkd.in/d7ar74Xy

👉SØG SØG DEL GERNE: Vi søger en engageret forskningskoordinator/Clinical Trial Manager til den nyetablerede Kliniske Akademiske Gruppe: “Sustainable Health Improvements Following #Obesity Treatment” forankret i forskningsgruppen Clinical Translational Metabolism (Torekov Group). Kirstine Nyvold Bojsen-Møller Julie Kloppenborg Andreas Mæchel Fritzen Trine Nielsen Nadia Micali Rikke Andersen Thomas Bandholm Christoffer Clemmensen Carsten Dirksen Bodil Just Christensen Lise Lotte Gluud Louise Groth Grunnet Berit L Heitmann Jørn W Helge Rikke Beck Jensen Jeanette Wassar Kirk Steen Larsen Asger Bach Lund Gitte Ravn-Haren Erik A. Richter Mathias Ried-Larsen Lykke Sylow Rebecca Vinding Rasmus Michael Sandsdal Simon Birk Kjær Jensen Sarah Byberg Dorthe Baunbjerg Nielsen Joachim Holt Matteo Fiorenza Mikkel Handel Noer Department of Biomedical Sciences Faculty of Health and Medical Sciences, UCPH Amager og Hvidovre Hospital Københavns Universitet - University of Copenhagen Ruth Frikke-Schmidt Trine Middelbo

Exciting job opening as Clinical Innovation Director at BETA.HEALTH® – An innovation platform sponsored by the Novo Nordisk Foundation team at Rigshospitalet. In order to ensure an even stronger relevance and link to our clinical innovators and clinical departments, we have a new role as Clinical Innovation Director at BETA.Health here at Rigshospitalet. The position is part-time (approx. one day a week with flexibility). The person will be part of the programme management together with me and work in collaboration with our partnerhospitals across Denmark. Please see the job description below and feel free reach out. I hope you will help share the post! Have a great summer! https://lnkd.in/dzHC4KCW

Are you looking for the next funding opportunity? Will your idea strengthen the #synergy between researchers across disciplines? Maybe its creative, novel and high-risk/high-gain #interdisciplinary #research? Novo Nordisk Foundation's Interdisciplinary Synergy Programme 2024 is something for you! Deadline is May 29 2pm. This grant opportunity seeks to support fundamental research between technology readiness levels (TRL) 1 and 2. Read more:

📣 📣 📣 The BRIDGE - Translational Excellence Programme is calling for applicants for its new BRIDGE Omics Programme 🔵🔘⚪️ 🔬 Welcome to the world of omics, where the intricacies of biological systems are unravelled through the lens of high-throughput data generation and analysis. In this series of three courses, we provide a structured approach to understanding biological data, starting with the basic principles of genomics and progressing to advanced techniques in multi-omics analysis and systems biology. 👨⚕️ The courses are designed for postdoctoral researchers. Each course builds on the knowledge gained in the previous course, providing a seamless progression through the layers of omics data analysis. Through a combination of lectures, hands-on exercises and case studies, participants will gain a deep understanding of how omics is shaping modern biology and medicine. 🔵🔘⚪️ As a new initiative, we are opening three of the BRIDGE courses to a limited group of non-BRIDGE participants. 💻 This new initiative is called the BRIDGE Omics Programme. It is a 'mini-BRIDGE' programme consisting of a welcome meeting and the three Translational Discovery Omics courses: Omics I, Omics II and Omics III. The courses are free of charge and participants will attend the courses and social events in the same way as BRIDGE Fellows. The requirements to pass the courses are the same; full attendance and active participation are mandatory. 🔵🔘⚪️ 🧠 Do you know anyone who might be interested? If you know someone who might be interested in joining the BRIDGE Omics Programme, please share this news with them.   Detailed information about the programme, the course practicalities and how to apply can be found on the website: https://lnkd.in/dkwWgZ44   ❗❗❗ Application deadline is Wednesday 29 May 2024. Peter Garred Marianne Benn Trine Brøndt Nielsen Merete Mortensen Karoline Hovde Sabine Kayser Tuomas Kilpeläinen Laura Maarit Pikkupeura Torben Hansen Jesper Velgaard Olsen Kristina B. Emdal, PhD Moreno Papetti, PhD Mette Korre Andersen Novo Nordisk Novo Nordisk Foundation Center for Basic Metabolic Research Novo Nordisk Foundation Center for Protein Research, University of Copenhagen

Skal du med til årets symposium om artrose? Så skal du sikre dig en af de sidste 30 pladser. Tilmeld dig her https://lnkd.in/dzK5Aw7i Greater Copenhagen Health Science Partners

🚀 Exciting Opportunity Alert! 🚀 Are you ready to take your lab to the next level of innovation? The School of Health Innovation is thrilled to announce that APPLICATIONS ARE NOW OPEN for Course 3: The School of Health Innovation for Professors and Managers! 🔍 Explore ways to increase innovation in your lab. 👩🔬 Learn how to combine your role as a scientist with that of a health innovator. 🌟 Dive into topics such as commercialization of research-based inventions, perfecting your pitch, and formulating effective business models based on your research ideas. Here are the details: 📅 Date: June 12th - 13th, 2024 📍 Location: Copenhagen, Denmark 👥 Participants: Assist., Assoc., and full professors, group leaders, managers, clinicians, and research coordinators from public universities or hospitals in Sweden, Denmark, and Norway. 📝 Don't miss out on this incredible opportunity! Apply now to secure your spot. Admission is on a first-come, first-served basis. 💼 Maximum capacity: 20 participants from partner countries (SE, NO, DK) 💰 Costs: FREE! Travel, food, and accommodation expenses covered. Travel expenses reimbursed up to 2,000 DKK. 📚 Check out the learning outcomes and programme details from our previously here: https://lnkd.in/eSUwZRvX 🌐 APPLY NOW: https://lnkd.in/d77UYty6 Join us for an enriching experience where you'll gain valuable insights, network with peers, and unleash the full potential of your research. Let's innovate together! The School of Health Innovation is a collaboration between Karolinska Institutet, Universitetet i Oslo (UiO), Norwegian University of Science and Technology (NTNU), and Københavns Universitet - University of Copenhagen. Sponsored by Novo Nordisk Foundation. Tonje Steigedal, PhD, Dr. Samer Yammine, Bjarte Reve, Katrine Langvad Stensløkken, Norunn Torheim, Lilian Rasmussen, Katrine Damgaard, Lene Nørby Nielsen, Maj Britt Larsen, Trine Nygaard Jørgensen, Kamilla Rolsted, Dr. Neta Kela Madar, Anna Vestergård Jacobsen, Peter Løvschall, Benedicte Smith-Sivertsen, Cecilie Ydemann Hansen, Trine Winterø, Hilde Nebb, Carl Johan Sundberg, Brita Pukstad, Veksthuset for verdiskaping – UiO Growth House, UBE | Karolinska Institutet, KU Lighthouse‎. #HealthInnovation #Research #Innovation #Academia #Leadership #Entrepreneurship #Science #LearningOpportunity

Systemically delivered hedgehog inhibitors, including vismodegib and sonidegib, are widely used to treat basal cell carcinomas (BCCs). Ablative fractional laser (AFL)-assisted topical delivery of vismodegib has shown promise in preclinical studies. This explorative clinical study aimed to evaluate intratumoral vismodegib concentrations and their effect on hedgehog pathway gene expression following AFL-assisted topical vismodegib delivery to BCCs... To read the full article, visit https://lnkd.in/g8DJA_zg Enjoy this open access article. ASLMS members receive full access to all journal articles. Not a member? Visit www.aslms.org to learn more about becoming an ASLMS member today! #aslms #LasersinSurgeryandMedicine #laser #ablative fractional laser #basalcellcarcinoma #clinicaltrial #emulsiondrugformulation #laserassisteddrugdelivery #vismodegib